878-16001-43982
2 vaccinations
6 coded responses
22 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 274 / NC
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Pfizer-BioNTech
- 2021-01-02
- 2021-01-03
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-16
-
2021-01-22
Dose 2 — Pfizer-BioNTech
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-25
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Left axillary lymphadenopathy began day two after second dose and has continued. Today I developed mild left anterior cervical lymphadenopathy as well. The pain and swelling are mild.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Continuing left axillary lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Left axillary lymphadenopathy continuesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: PainFree text: Left axillary lymphadenopathy is still there. Pain is decreased but still swollenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymphadenopathy of the left axilla is minimal at this point.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-12
- 2021-02-22
- 2021-02-26
- 2021-03-05
- 2021-04-23
- 2021-07-23
- 2022-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Lymphadenopathy
Systemic reaction (other): Left axillary lymphadenopathy began day two after second dose and has continued. Today I developed mild left anterior cervical lymphadenopathy as well. The pain and swelling are mild.
Systemic reaction (other): Continuing left axillary lymphadenopathy
Systemic reaction (other): Left axillary lymphadenopathy continues
Systemic reaction (other): Left axillary lymphadenopathy is still there. Pain is decreased but still swollen
Release 3 — day 7, dose 2
Systemic reaction (other): Lymphadenopathy of the left axilla is minimal at this point.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release